NASDAQ
MAIA Biotechnology, Inc. (MAIA) has a free cash flow growth of 24.35% as of Friday, May 29, 2026. This represents a 206.31% increase compared to its 12-month average of -22.90%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.